Weight loss

22°

Weather

YnetGlobal Channels

Sites & Sources

more channels

Contact

Weight loss

זריקת הרזיה וויגובי, מונג'רו, אלי לילי, נובו נורדסיק

Eli Lilly’s new weight loss pill delivers results but faces tempered market reaction

Orforglipron, the first oral GLP-1-based weight loss pill, shows promising clinical trial results, with an average 12.4% body weight reduction at highest dose; despite benefits, lower efficacy compared to injectables dampens investor enthusiasm

Eitan Gefen | 08.14.25

Cutting calories and still can't lose weight? Here's why

You’re working out and cutting calories, yet the scale won’t budge; a groundbreaking study points to why — and it’s not just about how much you eat, but what you eat

Eitan Gefen | 08.12.25

Mounjaro vs. Wegovy: Which is the best weight-loss drug?

Study finds Eli Lilly’s Mounjaro leads to significantly greater weight loss than Wegovy, highlighting its dual-hormone advantage, while both drugs face access challenges and pharmaceutical competition

Oren Reiss | 05.16.25

Weight loss drug shows promise in treating severe fatty liver disease, study finds

A landmark clinical trial reveals that the weight-loss drug Wegovy significantly improves liver health in patients with fatty liver disease, offering a potential breakthrough for millions worldwide

Oren Reiss | 05.03.25

Ozempic and the new weight-loss economy

Convergence of technology and medicine holds potential to deliver more accurate outcomes, preserve muscle mass and reduce side effects—while giving rise to a rapidly expanding market worth hundreds of billions of dollars

Dr. Merav Mor | 04.05.25

Breakthrough in nephrology: Ozempic slows kidney disease progression by 24%

Ozempic, known for weight loss and diabetes care, now EU-approved to cut kidney disease risk in type 2 diabetes; studies show it slows kidney disease by 24%, reduces mortality by 20% and lowers heart attack and stroke risks

Tzur Gueta | 12.16.24

Sad? Go for a run: This is how running will make you happier

Can running replace therapy? Running is more than fitness as it improves our self image, boosts positive hormones, and is even a substitute for meditation

Yogev Israeli | 12.10.24

New drug leads the weight loss injection market

Report shows Eli Lilly's Mounjaro outpaces Wegovy in weight-loss trial, as participants lost an average of 20% body weight with Mounjaro over 72 weeks, compared to 13.7% with Wegovy

Tzur Gueta | 12.05.24

Israel approves Rezin weight loss pill for indefinite use

Health Ministry lifts a 3-month limit previously imposed following a series of successful studies; 'The most important factor in our decision was the well-being of the patients' says Dr. Rakefet Bachrach

Tzur Gueta | 11.26.24

Counterfeit diabetes, weight-loss drugs raise alarm after series of fatalities

Reports indicate 10 deaths and over 100 hospitalizations may be linked to counterfeit semaglutide, found in knockoffs of weight-loss drugs like Ozempic; manufacturer warns unregulated versions, not FDA-approved, could endanger public health

Tzur Gueta | 11.09.24

Israeli weight loss pill makes history with FDA approval

The Israeli Epitomee pharmaceutical company receives FDA approval for new weight loss pill which expands in the stomach and does not contain an active agent; Will the Israeli pill sway the market?

Dr. Lior Neuman | 09.26.24

A new weight loss injection is coming to Israel

Eli Lilly announces it's new Mounjaro injection will be avaliable in the country from September 15, but how effective is it and how does it compare to Ozempic?

Ron Crissy | 09.12.24

How to avoid common mistakes when attempting to lose weight

A clinical dietitian explains why it’s so hard for us to stick to a weight-loss plan—and how we can overcome it, maybe even with surprising ease

Ziv Zafrani | 08.25.24

נשיא רוסיה פוטין ו רודן צפון קוריאה קים ג'ונג און ב פסגה ב פיונגיאנג

North Korea seeks new drugs to treat Kim Jong Un's obesity

North Korean leader estimated to weigh over 308 pounds, putting him at high risk of conditions like heart disease, high blood pressure and diabetes, which he has reportedly experienced since his early 30s

Ynetnews | 08.02.24

Yogurt makers see US sales rise, driven by weight-loss drugs revolution

Ozempic revolution negatively impacts market value of food and drink companies while creating opportunities for those offering low-sugar, high-protein and nutrient-rich products

Ynetnews | 06.27.24